Aardvark Therapeutics, Inc.
AARD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001774857
In the last 90 days, Aardvark Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $55.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aardvark Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $395.0K in total
- Insiders trading
- 1
- Net value
- −$395.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aardvark Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sun Nelson | See Remarks | 35,475 | Sep 11, 2026 | 3 |
| Chi Jeffrey | Director | 133,364Indirect | Aug 21, 2026 | 1 |
| Graf Susan E | Director | – | Aug 21, 2026 | 1 |
| Baynes Roy D. | Director | – | Aug 21, 2026 | 1 |
| Tong Victor Edward Jr | Director | – | Aug 21, 2026 | 1 |
| Lee Tien-Li | Chief Executive Officer | 1,551,613 | Feb 11, 2026 | 3 |
| Jaiman Manasi | Chief Medical Officer | – | Feb 11, 2026 | 1 |
| Jones Bryan | Chief Operating Officer | 1,250 | Oct 16, 2025 | 1 |
| Cui Xiangmin | 10% Owner | 958,412Indirect | Feb 19, 2025 | 0 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10% Owner | 958,412Indirect | Feb 19, 2025 | 0 |
| Decheng Capital Management IV (Cayman), LLC | 10% Owner | 958,412Indirect | Feb 19, 2025 | 0 |
| Decheng Capital Global Healthcare Fund (Master), LP | 10% Owner | 958,412Indirect | Feb 19, 2025 | 0 |
| Decheng Capital Global Healthcare GP, LLC | 10% Owner | 958,412Indirect | Feb 19, 2025 | 0 |
| Cormorant Asset Management, LP | Other: Former 10% Owner | 987,689Indirect | Feb 19, 2025 | 0 |
| Chen Bihua | Other: Former 10% Owner | 987,689Indirect | Feb 19, 2025 | 0 |
| Vickers Venture Fund VI Pte Ltd | 10% Owner | 2,050,902Indirect | Feb 19, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 (view filing)8:14 PM ET | Sep 10-11 | 1 day | Sun NelsonSee Remarks | SSaleCommon Stock, par value $0.00001 per share | −76.8K | $5.15 | −$395.0K | −68.4%35.5K after | 2 lots10b5-1 |
| Dec 12, 2025 (view filing) | Dec 11 | 1 day | Sun NelsonChief Financial Officer | PPurchase | +3.00K | $14.40 | +$43.2K | +2.8%108.5K after | |
| Dec 12, 2025 (view filing) | Dec 11 | 1 day | Lee Tien-LiChief Executive Officer | PPurchase | +7.00K | $14.49 | +$101.4K | +0.5%1.55M after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Lee Tien-LiChief Executive Officer | PPurchase | +10.0K | $9.66 | +$96.6K | +0.7%1.54M after | 2 lots |
| Sep 12, 2025 (view filing) | Sep 10-12 | 2 days | Lee Tien-LiChief Executive Officer | PPurchase | +20.0K | $8.03 | +$160.6K | +1.3%1.53M after | 3 lots |
| Sep 10, 2025 (view filing) | Sep 9 | 1 day | Sun NelsonChief Financial Officer | PPurchase | +6.00K | $8.07 | +$48.4K | +6.0%105.5K after | |
| Feb 19, 2025 (view filing)5:44 PM ET | Feb 14 | 5 days | Cui Xiangmin and 4 others10% Owner | PPurchase | +1.25M | $16.00 | +$20.0M | New position958.4K after | 2 lots |
| Feb 19, 2025 (view filing)4:02 PM ET | Feb 14 | 5 days | Cormorant Asset Management, LP and 1 otherOther: Former 10% Owner | PPurchase | +187.5K | $16.00 | +$3.00M | +23.4%987.7K after | |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Lee Tien-LiChief Executive Officer | PPurchase | +16.5K | $16.00 | +$264.7K | +1.1%1.50M after | |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Sun NelsonChief Financial Officer | PPurchase | +10.0K | $16.00 | +$160.0K | +11.2%99.5K after |